Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The cost-effectiveness of prenatal screening for spinal muscular atrophy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The cost-effectiveness of prenatal screening for spinal muscular atrophy.
The cost-effectiveness of prenatal screening for spinal muscular atrophy. Am J Obstet Gynecol. 2010 Mar; 202(3):253.e1-7.
View in:
PubMed
subject areas
Cost-Benefit Analysis
Cost-Benefit Analysis
Decision Support Techniques
Decision Support Techniques
Female
Female
Genetic Carrier Screening
Genetic Carrier Screening
Genetic Testing
Genetic Testing
Humans
Humans
Pregnancy
Pregnancy
Prenatal Diagnosis
Prenatal Diagnosis
Quality-Adjusted Life Years
Quality-Adjusted Life Years
Spinal Muscular Atrophies of Childhood
Spinal Muscular Atrophies of Childhood
Survival of Motor Neuron 1 Protein
Survival of Motor Neuron 1 Protein
authors with profiles
Sarah E Little